menu
    • menu

    Company profile for INmune Bio

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    INmune Bio Inc. is a clinical stage immuno-oncology company focused on harnessing the patient’s immune system to treat cancer. INKmune, the company’s lead product, primes patient’s NK cells (natural killer cells) to kill cancer. INmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. By controlling residual disease, patients may live longer. Using a ...
    INmune Bio Inc. is a clinical stage immuno-oncology company focused on harnessing the patient’s immune system to treat cancer. INKmune, the company’s lead product, primes patient’s NK cells (natural killer cells) to kill cancer. INmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. By controlling residual disease, patients may live longer. Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells’ ability to eliminate residual disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    INmune BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1200 Prospect Street Suite 525 La Jolla, California 92037
    Telephone
    Telephone
    858 964 3720
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.inmunebio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/inmune-bio-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/INmuneBio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Peer Study Highlights Therapeutic Potential of CORDStrom Platform
    Peer Study Highlights Therapeutic Potential of CORDStrom Platform

    05 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/05/3200582/0/en/Peer-Reviewed-Study-Highlights-Therapeutic-Potential-Around-Application-of-Stromal-Cell-Therapies-Such-as-INmune-Bio-s-CORDStrom-Platform.html

    GLOBENEWSWIRE
    05 Dec 2025
    Share Share
    Inmune Bio Presents Phase 2 Imaging Data At CTAD Conference
    Inmune Bio Presents Phase 2 Imaging Data At CTAD Conference

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196950/0/en/INmune-Bio-Reports-New-Phase-2-Grey-Matter-Imaging-Data-at-CTAD-Conference-Reinforcing-XPro1595-s-Evidence-Base-in-High-Inflammation-Alzheimer-s-Patients.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Inmune Bio To Present Twice At 18th Annual CTAD Conference
    Inmune Bio To Present Twice At 18th Annual CTAD Conference

    18 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/18/3189923/0/en/INmune-Bio-Announces-Two-Presentations-at-the-Upcoming-18th-Annual-CTAD-Conference.html

    GLOBENEWSWIRE
    18 Nov 2025
    Share Share
    Inmune Bio Reveals Q3 2025 Results and Business Update
    Inmune Bio Reveals Q3 2025 Results and Business Update

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177900/0/en/INmune-Bio-Inc-Announces-Third-Quarter-2025-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Inmune Bio To Release Q3 2025 Financials And Corporate Update
    Inmune Bio To Release Q3 2025 Financials And Corporate Update

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3171880/0/en/INmune-Bio-Inc-to-Report-Third-Quarter-2025-Financial-Results-and-Provide-a-Corporate-Update-on-Thursday-October-30-2025.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share
    Inmune Bio Joins Dermatologic Rare Disease Panel at Growth Summit
    Inmune Bio Joins Dermatologic Rare Disease Panel at Growth Summit

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166018/0/en/INmune-Bio-to-Participate-in-Dermatologic-Rare-Disease-Panel-at-the-Maxim-Growth-Summit-2025.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search